These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8835883)
1. A pilot study of prednisone in Alzheimer's disease. Aisen PS; Marin D; Altstiel L; Goodwin C; Baruch B; Jacobson R; Ryan T; Davis KL Dementia; 1996; 7(4):201-6. PubMed ID: 8835883 [TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Aisen PS; Davis KL; Berg JD; Schafer K; Campbell K; Thomas RG; Weiner MF; Farlow MR; Sano M; Grundman M; Thal LJ Neurology; 2000 Feb; 54(3):588-93. PubMed ID: 10680787 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial. Aisen PS Acta Neurol Scand Suppl; 2000; 176():85-9. PubMed ID: 11261810 [TBL] [Abstract][Full Text] [Related]
5. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051 [TBL] [Abstract][Full Text] [Related]
6. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C; Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766 [TBL] [Abstract][Full Text] [Related]
7. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response. Licastro F; Morini MC; Polazzi E; Davis LJ J Neuroimmunol; 1995 Mar; 57(1-2):71-5. PubMed ID: 7535791 [TBL] [Abstract][Full Text] [Related]
9. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension. Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of prednisone in Alzheimer's disease. Koch HJ; Szecsey A Neurology; 2000 Oct; 55(7):1067. PubMed ID: 11061280 [No Abstract] [Full Text] [Related]
11. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. Ferraccioli G; Salaffi F; De Vita S; Casatta L; Bartoli E J Rheumatol; 1996 Apr; 23(4):624-8. PubMed ID: 8730115 [TBL] [Abstract][Full Text] [Related]
12. Colchicine versus prednisone as treatment of usual interstitial pneumonia. Douglas WW; Ryu JH; Bjoraker JA; Schroeder DR; Myers JL; Tazelaar HD; Swensen SJ; Scanlon PD; Peters SG; DeRemee RA Mayo Clin Proc; 1997 Mar; 72(3):201-9. PubMed ID: 9070193 [TBL] [Abstract][Full Text] [Related]
13. Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease. Kalaria RN; Perry G Brain Res; 1993 Dec; 631(1):151-5. PubMed ID: 7507788 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study. Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965 [TBL] [Abstract][Full Text] [Related]
15. Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study. Ohnuma T; Toda A; Kimoto A; Takebayashi Y; Higashiyama R; Tagata Y; Ito M; Ota T; Shibata N; Arai H Clin Interv Aging; 2016; 11():29-36. PubMed ID: 26811674 [TBL] [Abstract][Full Text] [Related]
16. Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Rozemuller JM; Stam FC; Eikelenboom P Neurosci Lett; 1990 Oct; 119(1):75-8. PubMed ID: 1711182 [TBL] [Abstract][Full Text] [Related]
17. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group. Lande MB; Gullion C; Hogg RJ; Gauthier B; Shah B; Leonard MB; Bonilla-Felix M; Nash M; Roy S; Strife CF; Arbus G Pediatr Nephrol; 2003 Apr; 18(4):342-6. PubMed ID: 12700959 [TBL] [Abstract][Full Text] [Related]
19. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. Alvarez F; Ciocca M; CaƱero-Velasco C; Ramonet M; de Davila MT; Cuarterolo M; Gonzalez T; Jara-Vega P; Camarena C; Brochu P; Drut R; Alvarez E J Hepatol; 1999 Feb; 30(2):222-7. PubMed ID: 10068099 [TBL] [Abstract][Full Text] [Related]
20. Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease. Nilsson LN; Das S; Potter H Neurochem Int; 2001; 39(5-6):361-70. PubMed ID: 11578771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]